M3, Inc. provides medical-related services to physicians and other healthcare professionals through the internet. It operates m3.com, a members-only website for providing information, tools, and services for medical professionals; MR-kun which delivers the latest medical information for daily medical practice; QOL-kun, a marketing support service that provides selected information useful for doctors; m3.com CAREER, a physician recruitment and career change support site; and Yakucari, a job search website for pharmacists. The company also provides online lectures; clinical trial; research targeting domestic medical professionals; medical-related self-planned data and research reports; global health professional research; survey panel provision services; and m3.com opening and management services. In addition, it offers AskDoctors, where registered doctors answer questions about health and illness from the public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides services for pharmaceutical companies; and drug information database. Further, the company is involved in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; Support for recruiting subjects necessary for clinical development and clinical research, and related tasks; provision of management support to medical institutions, as well as visiting nursing, day care, and home care support services; and operates podiatry and venous disease clinics, and hospice facilities. Additionally, it offers clinical and medico-political news and education for medical professionals. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Visit company website
5 years, 6 months ago
M3, Inc is currently in a long term downtrend where the price is trading 5.0% below its 200 day moving average.
From a valuation standpoint, the stock is 52.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 33.6.
M3, Inc's total revenue rose by 40.1% to $49B since the same quarter in the previous year.
Its net income has increased by 77.5% to $12B since the same quarter in the previous year.
Finally, its free cash flow grew by 207.6% to $10B since the same quarter in the previous year.
Based on the above factors, M3, Inc gets an overall score of 4/5.